Evidence-Based Medicine Guidelines
Hemiarginate in acute porphyria
Hemiarginate in acute porphyria is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hemiarginate in Acute Porphyria." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria.
Hemiarginate in acute porphyria. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria. Accessed March 23, 2023.
Hemiarginate in acute porphyria. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria
Hemiarginate in Acute Porphyria [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hemiarginate in acute porphyria
ID - 455075
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
